Amgen studying genes to target pain conditions
For the next year, Amgen and Boston Children’s Hospital will use genetic analysis to study pain sensitivity. The biotech giant based in Thousand Oaks will work with patients who have abnormal pain conditions, and the hospital will validate genetic markers as potential targets for new therapies, the two announced in a press release on Oct. 16. “Traditional Read More →
Amgen settles with AbbVie over Humira biosimilar litigation
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Santa Barbara companies shine at Sandbox Startup Mashup
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Marian Regional Medical Center expands health care options
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Cal Poly SLO to study Diablo Canyon closure
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
SimpliPhi Power to provide off-grid energy storage system in New Zealand
Ojai-based SimpliPhi Power announced Oct. 3 that it had contracted with electricity distributor Powerco to build an off-grid renewable energy storage system called Base Power in New Zealand. The system provides supplemental or alternative energy to areas where upgrades to the network were not deemed to be cost effective. After initial trials, Powerco ordered 20 Read More →
Oak Therapeutics touts study results for dissolvable strips
Oak Therapeutics, based in Oxnard, announced that it completed a study of the use of its dissolvable strips to administer an anti-tuberculosis treatment orally. A 300 milligram dose of isoniazid on the dissolvable strips given to canines entered the bloodstream at a statistically similar rate to commercial tablets, the study found. The company, a subsidiary Read More →
